DNA ethenobases are promutagenic lesions formed by carcinogens such as vinyl chloride (VC). Their formation was investigated in 6-week old, male Sprague-Dawley rats exposed to 500 p.p.m. VC by inhalation (4 h/day, 5 days/ week) for 1, 2, 4 or 8 weeks and in 7-and 14-week old, matched control animals. l/v*-Ethenoadenine (eA) and 3, A^-ethenocytosine (eC) deoxyribonucleotides were analysed by immunoaffinity purification and 32 P-postlabelling. This postlabelling method was compared with a radioimmunoassay method, which yielded similar results. Background levels of ethenobases were found in DNA from the liver, lungs, kidneys and circulating lymphocytes of unexposed, control rats. In the liver, the following background molar ratios of ethenobase to parent base in DNA were detected (mean valuesxlO" 8 ): eA/A, 0.04-0.05; eC/C, 0.06-0.07. In the lungs, kidneys and circulating lymphocytes, background levels of eA and eC ranged from 1.7 to 4.2 XlO" 8 and from 4.8 to 11.2X10-", respectively. Following a 5-day exposure to VC, a significant increase of eA and eC was measured in hepatic DNA from rats sacrificed immediately after treatment Further, a dose-dependent increase of both etheno adducts was observed in liver DNA of VC-treated rats. Compared to the 5-day exposure, ~4-fold higher levels of eA and eC were observed in the liver of animals after 8 weeks of exposure. In contrast, there was an accumulation of eC but not of eA in lungs and kidneys. In circulating lymphocytes, no significant increase of ethenobase levels above control values was observed after 2 months of exposure to VC. Both etheno adducts were found to be persistent in liver DNA, after 2 months following the termination of VC exposure. These results further support the notion that DNA ethenobases are critical lesions in VC-induced carcinogenesis. The possible contribution of lipid peroxidation products that also yield ethenobases, on the formation and persistence of these DNA adducts, remains to be clarified.
Introduction
Ethenobases are exocyclic adducts formed with nucleobases by several carcinogens such as vinyl chloride (VC*) and urethane (reviewed in 1,2). Recent data indicate that they
•Abbreviations: VC, vinyl chloride; eA, l.JV'-ethenoadenine; eC, 3,N*-ethenocytosine; edAdo, l//-etheno-2'-deoxyadenosine; edCyd, B.yV'-etheno-2'-deoxycytidine; RIA, radioimmuno-assay; 3'-£dAMP, l/i' 6 -etheno-2'-deoxyadenosine 3'-monophosphate; 3'-edCMP, 3,// t -etheno-2'-deoxycytidine 3'-monophosphate; BSS, baJanced salt solution; PBS, phosphate buffered saline; PEI, polyethylene imine.
could also be formed endogenously through the stimulation of lipid peroxidation (3) (4) (5) (6) (7) . DNA ethenobases exhibit promutagenic properties (8) (9) (10) (11) ; reviewed in 2,12), suggesting that they could be critical miscoding DNA lesions in chemical carcinogenesis. 7-(2-Oxoethyl)guanine, the major DNA adduct formed by VC, did not display these promutagenic properties (13) .
Following the identification of 7-(2-oxoethyl)guanine in liver DNA from rodents exposed to VC (14, 15) , Green and Hathway (16) were the first to present some evidence of the formation of 1 .A^-ethenoadenine (eA) and S^-ethenocytosine (eC) in liver DNA of rats exposed to VC for 2 years. In 1985, Laib et al. (17) reported the detection of A^-ethenoguanine in DNA hydrolysates from the liver of pre-weanling rats treated with [ 14 C]VC. Subsequently, A^-ethenoguanine was determined by isotope dilution mass spectrometry following electrophore-labelling in DNA hydrolysates from the liver, lung and kidney of pre-weanling and adult Sprague-Dawley rats exposed to 600 p.p.m. VC for 5 days, 4 h/day (18) (19) (20) . Following the production of monoclonal antibodies directed against l// 5 -etheno-2'-deoxyadenosine (edAdo) and 3^/V 4 -etheno-2'-deoxycytidine (edCyd), a sensitive technique, based on HPLC purification and a competitive radioimmuno-assay (RIA), permitted to demonstrate the formation of edAdo and edCyd in liver and lung DNA from 11-day old SpragueDawley rats treated with 2000 p.p.m. VC for 10 days (21) . The analysis by HPLC/RIA was further used to measure edAdo and edCyd in DNA samples from various tissues (liver, lung, brain) of 7-day old and from liver of 13-week old BD VI rats exposed to 500 p.p.m. VC, 7 h/day during 2 weeks (22) . Finally, a comparative study on the formation and persistence of the four VC-DNA adducts was carried out with 10-day old Sprague-Dawley rats exposed to 600 p.p.m. VC (4 h/day for 5 days). 7-(2-Oxoethyl)-guanine and the ethenobases were quantitated in the liver, lung and kidney: all three etheno adducts appeared to be persistent in liver DNA 2 weeks after the end of exposure (20) . At that time, a similar study on adult animals was not feasible because of the lower levels of DNA alkylation produced by VC in adult, as compared to young rats (19, 22, 23) .
Recently, an ultra-sensitive method, based on immunoaffinity purification and 32 P-postlabelling was developed to determine l,A*-etheno-2'-deoxyadenosine 3'-monophosphate (3'-edAMP) and 3,A*-etheno-2'-deoxycytidine 3'-monophosphate (3'-edCMP) in DNA (7, 24) . This technique permitted the detection of background levels of eA and eC in liver DNA samples from untreated rodents and from humans with unknown exposure (7) . In the present work, the accumulation and persistence of eA and eC was investigated by immunoaffinity/ Y.Guichard et al.
Chemical Co. (St Louis, MO) and from Pharmacia (Uppsala, Sweden). 3'-edAMP and 3'-edCMP were prepared by reaction of the parent nucleotide with 2-bromoacetaldehyde and purified by HPLC (24, 25 Monoclonal antibodies EM-A-1 and EM-C-1, raised against edAdo and edCyd, respectively, were obtained from Dr M.F.Rajewsky (University of Essen, Germany). Protein A-Sepharose CL4B was purchased from Pharmacia, cellulose MN300 from Macherey and Nagel (DUren, Germany), polyethylene imine (PEI) Corcat P600 from Virginia Chemicals (Portsmouth, VA) and hydroxyapatite (Bio-Gel HTP) from Bio-Rad Laboratories (Richmond, CA).
Micrococcal endonuclease (grade VI) and spleen phosphodiesterase (from calf spleen) were from Sigma, and T4 polynucleotide kinase from Pharmacia. The following enzymes were purchased from Boehringer-Mannheim (Mannheim, Germany): proteinase K, RNase (from bovine pancreas), DNase I (from bovine pancreas; grade II), snake venom phosphodiesterase (from Crotalus dunssus), alkaline phosphatase (from calf intestine; grade I).
Animals
Male Sprague-Dawley (OFA) rats, obtained from Iffa-Credo (L'Arbresle, France), were housed in a temperature and humidity controlled room with a 12 h light/dark cycle. They were given a commercial rat chow (Biscuits Extra Labo from Socie'te' Pietrement, Provins, France) and water ad libitum. Treatment was started after 1 week of adaptation to this chow.
VC exposure
For exposure to VC, animals were placed in an inhalation chamber with an airflow of ~15 chamber volume changes per hour, as described previously (22) . VC concentration at four different positions inside the chamber was monitored hourly by gas chromatography on Porapack QS (80-100 mesh, from Waters Associates, Milford, MA), with flame ionisation detection. The inhalation chamber was kept at the same housing conditions as described above and the animals had free access to food and water.
To examine the accumulation of VC-DNA adducts with increasing length of exposure, groups of five 6-week old rats were exposed to 500 p.p.m. VC, 4 h/day, 5 days/week, for 1, 2, 4 or 8 weeks. Animals were sacrificed immediately after the end of exposure. In another experiment designed to examine adduct persistence, 20 rats were exposed for 5 days to 500 p.p.m. VC (4 h/day) and groups of five rats were killed at different time intervals after the treatment, i.e. 0, 2, 4 or 8 weeks.
The control groups comprised male Sprague-Dawley rats that were housed under the same conditions and were sacrificed at the age of 7 or 14 weeks. Due to unavoidable constraints of space at the time this experiment was initiated, control rats could not be kept in our laboratory at the same time as treated animals. Therefore, we used control rats housed later in the same room under similar conditions. These animals were matched to the VC-exposed groups with regard to their source (Iffa Credo), age (7-and 14-week old), sex and diet.
Preparation of tissues and DNA isolation
Animals were killed by exsanguination (cardiac puncture) under ether anaesthesia. Blood was collected in hepannized tubes. Organs (liver, lungs, kidneys) were excised immediately, frozen in liquid nitrogen and kept at -80°C until further processing.
Mononuclear leucocytes were separated as follows. A 5% (w/v) solution of Dextran 200 000-400 000 (Fluka Chemie Ab, Buchs, Switzerland) was prepared in a balanced salt solution (BSS) consisting in a 14-5 mM Tris-HCl buffer (pH 7.6) containing 5 HM CaCI 2 , 98 uM MgCl 2 , 540 HM KC1, 126 mM NaCl and 555 uM glucose.
Blood (5 to 10 ml from each animal) was mixed with one volume of Dextran solution (by gentle inversion of the tube). After sedimentation of aggregated erythrocytes (30 min at room temperature), the leukocyte-rich supernatant was removed and layered onto a separation fluid (Mono-Poly Resolving Medium from Flow Laboratories SA, Les Ulis, France). Following centrifugation at 800 g for 15 min, mononuclear cells were recovered with a Pasteur pipette from the sample/medium interface, washed twice in three volumes of BSS, centrifuged at 400 g for 7 min, resuspended in 5 ml BSS and stored frozen at -80°C.
DNA was purified on hydroxyapatite according to the procedure of Mailer and Rajewsky (26) , with some modifications (7) . Frozen tissues were fragmented in liquid nitrogen in a mortar, transferred as 500 mg aliquots to 50 ml polypropylene tubes containing 5 ml 1% (w/v) sodium dodecylsulfate and homogenised with a Polytron apparatus (Kinematica, Lucerne, Switzerland). The homogenate was incubated in presence of 2.5 mg proteinase K for 1 h at 37°C and 10 h at room temperature. 0.5 mg of RNase (from beef pancreas; pre-heated for 10 min at 80°C) was added and the mixture was incubated for 1 h at 37°C. Proteins were extracted with a mixture of 20 ml of a urea buffer [180 mM sodium phosphate buffer (pH 6.8) containing 5 M urea and 2 M NaCl] and 25 ml of chloroform/isoamyl alcohol (25:1, v/v). After centrifugation, the aqueous phase was withdrawn carefully and mixed with 1.5 g hydroxyapatite (pre-washed in urea buffer at 80°C for 20 min). The suspension was incubated at room temperature for 30 min under gentle shaking, centrifuged at 800 g for 2 min, and the supernatant was discarded. The hydroxyapatite was washed six times with 30 ml of urea buffer, and once with 30 ml of a 1 mM sodium phosphate buffer (pH 6.8). The DNA was eluted three times with 3 ml of 0.5 mM sodium phosphate buffer. The supernatants were pooled and dialysed against distilled water for 12 h. The purity and concentration of DNA was estimated by the ratio of U V absorbencies at 260 and 280 nm. 100 ug aliquots were dried by centrifugation under vacuum with a Speed-Vac concentrator (Savant Instruments Inc., Farmingdale, NY) and stored at -80°C.
Enzymatic hydrolysis of DNA Hydrolysis to deoxyribonucleoside 3'-monophosphates was earned out in a 50 mM Tris-HCl buffer (pH 6.8) containing 10 mM CaCl 2 , micrococcal nuclease (0.1 U/|ig DNA) and spleen phosphodiesterase (0.05 U/|ig DNA, dialysed for 6 h against distilled water before use) (7). The reaction mixture (total volume, 800 (ll) was incubated at 37°C for 4 h. After addition of 2 to 3 volumes of cold ethanol, proteins were precipitated at -20"C for 30 min and removed by centrifugation. The supernatant was evaporated in a SpeedVac concentrator.
For the analysis by HPLC/RIA, DNA was hydrolysed using DNase I (50 (ig/mg DNA, 30 min, 37°C), snake venom phosphodiesterase and alkaline phosphatase (15 ng and 10 U/mg DNA, respectively, 2 h, 37°C), in a 0.05 M Tris-HCl buffer (pH 6.75) containing 0.01 M MgCI 2 (22) .
Analysis of3'-edAMP and 3'-edCMP
Following hydrolysis of DNA to 2'-deoxyribonucleoside 3'-monophosphates, 3'-edAMP and 3'-£dCMP were purified by immunoaffinity chromatography and quantitated by 32 P-postlabelling, as described previously (7, 24, 25) . In brief, immunoaffinity columns retaining specifically 3'-edAMP and 3'-edCMP were prepared by coupling monoclonal antibodies EM-A-1 and EM-C-1 (21), respectively, to a gel of protein A/Sepharose CL4B (24, 25) . These columns were stored at 4°C in phosphate buffered saline (PBS) containing 0.02% (w/v) sodium azide (PBS-azide). Before use, they were washed sequentially in water (2X5 ml), methanol/water (1:1, v/v; 3X5 ml), water (3X5 ml) and PBS (2X5 ml). A 175 nl aliquot from each DNA hydrolysate was loaded onto an EM-A-1 column, another 175 |il aliquot onto an EM-C-1 column, at 4°C. After elution of normal nucleotides in PBS (8X5 ml), the columns were washed in water (8X5 ml) and brought to room temperature Etheno adducts were eluted in methanol/water (1:1, v/v; 2X2.5 ml). Eluates of each sample from the two columns were pooled and dried by centrifugation under reduced pressure. Dried samples were stored at -80°C. After use, immunoaffinity columns were washed sequentially in methanol/water (1:1, v/v; 5 ml), water (5 ml) and PBS-azide (10 ml).
32 P-Postlabelling analysis was carried out as follows (7, 24, 27) . The dried samples (equivalent to 100 Jig DNA) obtained from the immunoaffinity columns were labelled in a 10 nl mixture containing 50 mM Tris-HCl (pH 6.8), 10 mM MgCl 2 , 10 mM dithiothreitol, 100 amol 3'-dUMP (internal standard), 10 nCi [f 32 P]ATP (final concentration, -200 nM) and 10 U T4 polynucleotide kinase. At the pH used (6.8), T4 polynucleotide kinase acts simultaneously as a 5'-kinase and 3'-phosphatase, thus converting deoxyribonucleoside 3'-monophosphates to deoxynbonucleoside 5'-[ 32 P]-monophosphates (27, 28) . A solution of standards containing 100 amol each of 3'-edAMP, 3'-edCMP and 3'-dUMP was labelled in parallel to the samples. The reaction mixtures were incubated at 37°C for 90 min, centrifuged and separated by two-dimensional TLC on PEI-cellulose plates (7, 24, 27) . The plates were developed in the first direction in 1 M acetic acid (pH 3.5, adjusted with ammonia) and in the second direction in saturated ammonium sulphate (pH 3.5, adjusted with H 2 SO 4 ). After autoradiography, spots corresponding to 5'-edAMP, 5'-edCMP and 5'-dUMP were cut out and the radioactivity was determined by liquid scintillation counting.
Normal deoxyribonucleoside 3'-monophosphates in DNA hydrolysates were quantitated by reverse-phase HPLC onto a Nucleosil Qg column (4.6 mmX25 cm; particle size, 10 |im; Soci£t£ Francaise Chromato Colonne, Gagny, France) (7, 25) . Elution was in 100 mM ammonium formate (pH 6.8) at a flow rate of 1 rruVmin and quantitation was based on UV absorbance at 254 nm. RNA contamination was also determined on the same chromatograms.
Etheno adduct levels were calculated as molar ratios of adduct to parent nucleotide in DNA (7) . The amounts in amol of etheno nucleotides resolved on the TLC plates are given by the formula 100X(F2/F,), where Fj and F 2 are the ratios of radioactivity (c.p.m.) of the etheno adduct to the internal standard (5'-dUMP), determined in the standard mixture and in the sample, respectively. Molar ratios eA/A and eC/C are then obtained by dividing by the amount of parent nucleotide measured in the HPLC analysis. 
RIA analysis of tdAdo and zdCyd
To further validate the immunoaffinity/ 32 P-postlabelling technique, etheno adducts in DNA were also determined as 2'-deoxyribonucleosides following HPLC separation and competitive RIA (21, 22) . DNA hydrolysates were separated on a Nucleosil C 18 reverse phase column (10 mmX25 cm, 5 u.m) using a gradient elution previously described (13, 22) . The eluate was monitored by UV absorbance at 254 nm and fractions containing individual 2'-deoxyribonucleosides were pooled. Normal nucleosides were quantitated by absorbance at 260 nm. Fractions corresponding to ethenonucleosides were freeze-dried and reconstituted in a small volume of RIA buffer. Competitive RIA for quantitating edAdo and EdCyd were carried out in presence of monoclonal antibodies EM-A-1 and EM-C-1, respectively, and of 
Statistics
Statistical analyses of the data were done using the one-way analysis of variance (ANOVA), the multiple comparison methods of Dunnett and Tukey and the two-sample Mest The regression lines for the accumulation of etheno adducts in different organs were compared using the analysis of covanance.
Results

Comparison of two methods for the analysis of eA and eC in DNA in vivo
The analysis by immunoaffinity/ 32 P-postlabelling developed previously (7, 24, 25) was further validated by comparison with a method based on HPLC pre-separation of the etheno-2'-deoxyribonucleosides and quantitation by a competitive RIA (21, 22) . Two liver DNA samples from 29-day old rats were analysed in duplicate. As shown in Table I , both methods yielded very similar values. Because the dosage by HPLC/ RIA required more than 2 mg of DNA, it was not possible to carry out a triplicate analysis of these samples.
Reproducibility of the analysis by immunoaffinity/ 32 F'-postlabelling
For both eA and eC, a coefficient of variation ranging from 9 to 26% was obtained after repeated analyses of liver DNA samples.
Endogenous formation of etheno adducts in DNA in vivo
The analysis of DNA samples from untreated adult rats (7-to 14-weeks old) revealed the presence of background levels of ethenobases in all the tissues investigated (Tables II and III) . In the lungs, kidneys and circulating lymphocytes, eA and eC levels (mean values) ranged from 1.7 to 4.2 and from 4.8 to 11.2 adducts/10 8 parent bases, respectively. Under these experimental conditions, the liver exhibited 40 to 100 times less eA and 70 to 180 times less eC than the other tissues examined. There were no significant increases in adduct levels between 7 and 14 weeks of age in any of the tissues examined in untreated animals. Therefore age-related changes in endogenous levels of etheno adducts over this time period are unlikely to explain the accumulation of adducts observed following VC treatment (see below). 
Accumulation of DNA etheno adducts following exposure to vinyl chloride
The formation and accumulation of ethenobases was analysed in adult rats exposed to 500 p.p.m. VC for various lengths of time (Figures 1 to 3) . The data points in Figures 1 to 3 represent the mean ± SD (error bars) of 3 to 8 analyses per group. Three to five individual samples were analysed within each group, some samples were analysed several times (up to 3). All analyses within a group were combined because variations between individual samples within a group were smaller than variations between analyses of the same sample. An accumulation of both eC and eA was observed in the liver during exposure (Figure 1 ). In contrast, in lungs and kidneys, eC but not eA accumulated in DNA (Figures 2 and 3) .
The regression lines representing the accumulation of DNA ethenobases (eA and eC in liver, Figurel; eC in lungs, Figure 2 ; eC in kidneys, Figure 3 ) were obtained using first order linear regression. The P values were =£ 0.001. Curve fitting was not significantly improved after transformation (e.g. log transformation) of the data. The following mean values were computed for the slopes, expressed as (molar ratio of ethenobase to parent base)X10~8X(week)" 1 : eA in liver, 0.682; eC in liver, 0.809; eC in kidneys, 1.12; eC in lungs, 3.87. Comparison of the regression curves by the analysis of covariance showed that they were all significantly different from each other (P < 0.0001; Table IV) . However, the rates of accumulation (slopes) of eA and eC in liver, and of eC in kidneys, were not very significantly different (fluctuation due to lack of parallelism, F 2; 49 = 3.30, P = 0.045). The accumulation rate of eC was higher in the lungs as compared to the kidneys (P = 0.035) and liver (P = 0.012).
Levels of eA found in lung DNA after various periods of exposure to VC were compared by ANOVA and Dunnett's test, using for the latter the control values measured in 7-week old animals. eA levels were significantly different from controls after 2, 4 or 8 weeks (P < 0.001) but not after 1 week (P > 0.05) of treatment. Levels measured between 2 and 8 weeks of exposure were not different (Tukey's test, P > 0.05), suggesting a steady state in the formation of eA after 2 weeks.
Several samples of mononuclear leucocytes from rats exposed to VC for 4 or 8 weeks were analysed (Table III) . As compared to controls, no significant increase of the levels of eA and eC was observed after 8 weeks of treatment (P > 0.05, Student's Mest), with this limited number of analyses.
Persistence of DNA etheno adducts in liver
The persistence of eA and eC in liver DNA was investigated in rats following a 5 day exposure to 500 p.p.m. VC. Adduct levels measured immediately after the treatment were: eA/ A = (0.71 ± 0.06) X10" 8 , eC/C = (2.86 ± 0.30) X10" 8 (n = 3). After 2 months, they were not significantly different (P > 0.05, Student's Mest): eA/A = (0.68 ± O.17)X1O-*, eC/ C = (2.34 ± 0.24)X10-8 (n = 3). These molar ratios being significantly higher than in 14-week old controls (P < 0.05), where eA/A = (0.043 ± 0.025) X10" 8 and eC/C = (0.062 ± 0.027) X10" 8 (n = 4) (Table II) , the present data suggest that ethenobases formed during exposure to VC are persistent in hepatic DNA.
Discussion
The aim of this study was to measure the formation of ethenobases in DNA from adult rats exposed to VC. Previously, this type of study was only feasible in pre-weanling animals, which exhibit higher levels of VC-DNA adducts than adults (20, 22) . The ultra-sensitive immuno-affinity/ 32 P-postlabelling method for measuring 3'-edAMP and 3'-edCMP residues in DNA (7, 24, 25) was further validated by comparison with an independent method based on HPLC separation and competitive RIA of the corresponding ethenodeoxyribonucleosides (21, 22) . As shown in Table I , both methods yielded very similar values. The immunoaffinity/ 32 P-postlabelling method also exhibited good reproducibility.
Using this new method, the formation of ethenobases was investigated in DNA from adult Sprague-Dawley rats exposed to 500 p.p.m. VC (4 h/day, 5 days/week) for up to 8 weeks. Accumulation curves were established for eA and eC in liver DNA (Figure 1 ), lung DNA ( Figure 2 ) and kidney DNA ( Figure 3 ). All these curves were significantly different, as demonstrated by analysis of covariance of the regression lines (Table IV) . Both ethenobases accumulated in liver DNA and eC, but not eA, accumulated in lung and kidney DNA during exposure to VC. These data could suggest a poor repair of eA and eC in liver and of eC in lungs and kidneys, under these experimental conditions, an explanation supported by the apparent persistence of eA and eC in liver DNA after the end of exposure. These data are in apparent contradiction with in vitro experiments showing an efficient release of ethenobases from DNA by a mammalian repair enzyme, the human N-alkylpurine-DNA glycosylase (29) or in presence of cell homogenates of mononuclear blood cells from humans (30) . More recently, it was found that eA and eC are excised by separate human DNA glycosylases, purified from HeLa cellfree extracts (31) . This raises the question of whether these separate repair activities could explain the differential accumulation of eA and eC observed in DNA from lungs ( Figure 2 ) and kidneys (Figure 3 ) of adult rats exposed to VC.
However, the interpretation of the observed accumulation and persistence of etheno adducts in DNA is not straightforward, due to the existence of a natural background (Tables  II and III) ; this background level varies significantly in rat liver and can be higher than reported in Table II and Fig. 1  (7) . Several lines of evidence point to lipid peroxidation products, presumably mwu-4-hydroxy-2-nonenal, as a possible endogenous source of this background (3-6) which was also observed in human liver samples and mouse tissues (2, 7) . In rodents, background levels of DNA ethenobases seem to vary with diet (7, 32) . Possibly they can be affected by exposure to environmental agents as oxidative metabolism of xenobiotics is often accompanied by an oxidative stress and stimulation of lipid peroxidation (33) (34) (35) (36) . Reactive oxygen species are produced as a result of uncoupling of cytochrome P450-catalysed monooxygenase reactions (33), the cytochrome P450 2E1 isoenzyme appearing as particularly effective in releasing such species and in inducing lipid peroxidation (34) . Treatment of rats with A^-nitrosoamines or aflatoxin B| leads to an enhanced pro-oxidant state and stimulation of lipid peroxidation, these effects appear to persist long after the treatment (35, 36) . In Sprague-Dawley rats (unpublished results), and humans (37), VC is mainly oxidised by cytochrome P450 2E1, yielding the ultimate carcinogenic metabolite, chloroethylene oxide, which rearranges spontaneously into 2-chloroacetaldehyde. 2-Chloroacetaldehyde has been shown to stimulate lipid peroxidation in isolated rat hepatocytes (38) . These data suggest that exposure to VC could be associated with a stimulation of lipid peroxidation in experimental animals. Therefore, the accumulation and persistence of ethenobases in DNA from rats exposed to VC could result both from a direct pathway involving chloroethylene oxide (39) (40) (41) and an indirect pathway involving lipid peroxidation products. Our previous data suggesting the persistence of ethenobases in liver DNA from pre-weanling rats after exposure to VC (20) also need to be reinterpreted in view of this endogenous formation. In fact, more recent analyses with the newly developed techniques indicated the presence of ethenobases in liver DNA from unexposed pre-weanling rats (Table I) .
The existence of a natural background in DNA will hamper the dosimetry of ethenobases at low levels of exposure to VC (or to other etheno adduct-forming carcinogens). In addition our analyses failed to reveal increased levels of DNA etheno adducts in easily accessible tissues, such as mononuclear blood cells, after prolonged inhalation exposure of rats to a high concentration of VC. Thus, biomonitoring of human exposure to VC on the basis of DNA etheno adducts in lymphocytes may not be feasible.
It has been suggested that ethenobases are critical promutagenic lesions involved in chemical carcinogenesis (2) . Our data do not show a correlation between total etheno adduct levels and organospecificiry of VC-induced carcinogenesis: the liver, the main target organ in Sprague-Dawley rats (42), did not exhibit higher levels of etheno adducts after VC exposure than the other tissues examined (Figures 1-3) . However, the accumulation of eA in liver DNA (Figure 1 ) could be implicated in VC-induced hepatocarcinogenesis. This accumulation was not observed in organs less susceptible to tumorigenesis such as lungs and kidneys (Figures 2 and 3) . Furthermore, VCinduced liver tumours in rats exhibit point mutations at AT base pairs in the Ha-ras (43) or p53 (unpublished results) genes, suggesting the involvement of eA as a promutagenic lesion (9) .
Further studies on the formation and repair of DNA ethenobases during VC-induced carcinogenesis are needed in order to elucidate the contribution from endogenous sources and the cell specificity of these processes.
